Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $90.2 million.

  • Avidity Biosciences' Prepaid Assets rose 17103.36% to $90.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.2 million, marking a year-over-year increase of 17103.36%. This contributed to the annual value of $40.8 million for FY2024, which is 15565.93% up from last year.
  • Per Avidity Biosciences' latest filing, its Prepaid Assets stood at $90.2 million for Q3 2025, which was up 17103.36% from $67.4 million recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Prepaid Assets registered a high of $90.2 million during Q3 2025, and its lowest value of $4.0 million during Q1 2021.
  • In the last 5 years, Avidity Biosciences' Prepaid Assets had a median value of $12.9 million in 2023 and averaged $23.9 million.
  • Per our database at Business Quant, Avidity Biosciences' Prepaid Assets skyrocketed by 47264.77% in 2021 and then tumbled by 2315.63% in 2022.
  • Quarter analysis of 5 years shows Avidity Biosciences' Prepaid Assets stood at $5.6 million in 2021, then surged by 118.2% to $12.2 million in 2022, then surged by 30.63% to $16.0 million in 2023, then skyrocketed by 155.66% to $40.8 million in 2024, then skyrocketed by 121.07% to $90.2 million in 2025.
  • Its Prepaid Assets stands at $90.2 million for Q3 2025, versus $67.4 million for Q2 2025 and $55.1 million for Q1 2025.